In this context, IgM-enriched IVIGs (IGAM), which in addition to IgG also contain IgM and IgA, are considered to have a more potent immunomodulatory capacity than conventional IVIG preparations [16] and may represent a promising treatment option in critical COVID-19. The gene discussed is CD40LG; the disease is COVID-19.